tirzepatide fda review says shortage of GLP-1 drug is over FDA Approves Mounjaro (tirzepatide) Injection

Novo Nordisk, the manufacturer, was required to run a trial that focused on CVD, with a secondary consideration on diabetic retinopathy

This shift indicates a broader trend among insurers, where approximately 60% of plans include medications for obesity-related conditions, though stringent criteria often apply

MOTS-C improves glucose uptake and fat oxidation during exercise

You'll always know what we're doing and why

For people with diabetes, orthostatic hypotension is more common because diabetes can damage the nerves that help control blood pressure

We calculate a specific starting dose for your transition to minimize side effects and ensure your progress continues